CompaniesAuron Therapeutics
Auron Therapeutics logo

Auron Therapeutics

active
Newton, MA, United States
Founded 2018
Website
About

Differentiation Therapy

Areas of Focus

Categories

Small Molecule PharmaceuticalBoston & New England
Team (26)
Alexandra Cantley, Ph.D.
Alexandra Cantley, Ph.D.
Auron Therapeutics
team_member
Alon Lazarus, Ph.D.
Alon Lazarus, Ph.D.
Auron Therapeutics
team_member
Anna French, Ph.D.
Anna French, Ph.D.
Auron Therapeutics
team_member
Briggs Morrison, M.D.
Briggs Morrison, M.D.
Auron Therapeutics
team_member
Caroline Almon, M.S.
Caroline Almon, M.S.
Vice President, Clinical Development
Auron Therapeutics
executive
Charles Rudin, M.D., Ph.D.
Charles Rudin, M.D., Ph.D.
Auron Therapeutics
team_member
View all 26 team members →
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

85

By Phase

PHASE1: 2

By Status

RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT05238558
NCT06846606
Hover over trial bars to see details

Recent Trials

NCT06846606Lead Sponsor
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
PHASE1Recruiting
69 participants
Started: May 1, 2025 · Completed: Jun 30, 2028
NCT05238558Lead Sponsor
Safety and Immune Response to FMPV-1
PHASE1Completed
16 participants
Started: Jan 31, 2022 · Completed: Jun 30, 2023
Funding History (5)
D
Dec 31, 2024
Filing
D/A
Oct 20, 2023
Filing
D
Jul 28, 2022
Filing
D
Dec 16, 2020
Filing
D
Jul 25, 2018
Filing
Locations (1)
Headquarters
Newton, MA, United States
Map

Loading map...